WINDTREE THERAPEUTICS INC /DE/ Selling, General and Administrative Expense
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Selling, General and Administrative Expense of $1.82 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-05-15
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for the quarter ending 2025-03-31 was $1.82M, a 15.43% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for the quarter ending 2024-12-31 was $2.23M, a 16.95% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for the quarter ending 2024-09-30 was $2.77M, a 7.48% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for the quarter ending 2024-06-30 was $1.59M, a 34.34% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for fiscal 2024 was $8.74M, a 4.95% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for fiscal 2023 was $9.20M, a 14.75% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for fiscal 2022 was $10.79M, a 25.45% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ selling, general and administrative expense for fiscal 2021 was $14.47M, a 3.15% decline from fiscal 2020.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.82M 10-Q · filed 2025-05-15 | $4.05M derived: sum of 2 quarters · filed 2025-05-15 | $6.82M derived: sum of 3 quarters · filed 2025-05-15 | $8.41M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $5.00M derived: sum of 2 quarters · filed 2025-04-15 | $6.59M derived: sum of 3 quarters · filed 2025-04-15 | $8.74M 10-K · filed 2025-04-15 |
| 2024-09-30 | $2.77M 10-Q · filed 2024-11-26 | $4.36M derived: sum of 2 quarters · filed 2024-11-26 | $6.51M 10-Q · filed 2024-11-26 | $8.42M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $1.59M 10-Q · filed 2024-08-19 | $3.74M 10-Q · filed 2024-08-19 | $5.65M derived: sum of 3 quarters · filed 2025-05-15 | $8.23M derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $2.15M 10-Q · filed 2025-05-15 | $4.06M derived: sum of 2 quarters · filed 2025-05-15 | $6.64M derived: sum of 3 quarters · filed 2025-05-15 | $9.06M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $4.49M derived: sum of 2 quarters · filed 2025-04-15 | $6.91M derived: sum of 3 quarters · filed 2025-04-15 | $9.20M 10-K · filed 2025-04-15 |
| 2023-09-30 | $2.58M 10-Q · filed 2024-11-26 | $5.00M derived: sum of 2 quarters · filed 2024-11-26 | $7.29M 10-Q · filed 2024-11-26 | $9.53M derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-06-30 | $2.42M 10-Q · filed 2024-08-19 | $4.71M 10-Q · filed 2024-08-19 | $6.95M derived: sum of 3 quarters · filed 2024-08-19 | $9.61M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $2.29M 10-Q · filed 2024-05-15 | $4.53M derived: sum of 2 quarters · filed 2024-05-15 | $7.19M derived: sum of 3 quarters · filed 2024-05-15 | $10.09M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $4.89M derived: sum of 2 quarters · filed 2024-04-16 | $7.80M derived: sum of 3 quarters · filed 2024-04-16 | $10.79M 10-K · filed 2024-04-16 |
| 2022-09-30 | $2.65M 10-Q · filed 2023-11-09 | $5.56M derived: sum of 2 quarters · filed 2023-11-09 | $8.55M 10-Q · filed 2023-11-09 | $11.51M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.91M 10-Q · filed 2023-08-07 | $5.89M 10-Q · filed 2023-08-07 | $8.86M derived: sum of 3 quarters · filed 2023-08-07 | $12.33M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $2.99M 10-Q · filed 2023-05-15 | $5.95M derived: sum of 2 quarters · filed 2023-05-15 | $9.42M derived: sum of 3 quarters · filed 2023-05-15 | $12.79M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $6.43M derived: sum of 2 quarters · filed 2023-03-31 | $9.80M derived: sum of 3 quarters · filed 2023-03-31 | $14.47M 10-K · filed 2023-03-31 |
| 2021-09-30 | $3.47M 10-Q · filed 2022-11-14 | $6.84M derived: sum of 2 quarters · filed 2022-11-14 | $11.51M 10-Q · filed 2022-11-14 | $14.93M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $3.37M 10-Q · filed 2022-08-11 | $8.04M 10-Q · filed 2022-08-11 | $11.47M derived: sum of 3 quarters · filed 2022-08-11 | $16.29M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $4.67M 10-Q · filed 2022-05-05 | $8.10M derived: sum of 2 quarters · filed 2022-05-05 | $12.92M derived: sum of 3 quarters · filed 2022-05-05 | $16.37M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $8.25M derived: sum of 2 quarters · filed 2022-03-31 | $11.70M derived: sum of 3 quarters · filed 2022-03-31 | $14.94M 10-K · filed 2022-03-31 |
| 2020-09-30 | $4.82M 10-Q · filed 2021-11-10 | $8.28M derived: sum of 2 quarters · filed 2021-11-10 | $11.52M 10-Q · filed 2021-11-10 | $13.93M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $3.45M 10-Q · filed 2021-08-05 | $6.70M 10-Q · filed 2021-08-05 | $9.11M derived: sum of 3 quarters · filed 2021-08-05 | $12.50M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $3.24M 10-Q · filed 2021-05-13 | $5.66M derived: sum of 2 quarters · filed 2021-05-13 | $9.05M derived: sum of 3 quarters · filed 2021-05-13 | $12.29M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $2.41M 10-K · filed 2020-04-03 | $5.81M derived: sum of 2 quarters · filed 2020-11-16 | $9.05M derived: sum of 3 quarters · filed 2020-11-16 | $12.40M 10-K · filed 2021-03-29 |
| 2019-09-30 | $3.40M 10-Q · filed 2020-11-16 | $6.63M derived: sum of 2 quarters · filed 2020-11-16 | $9.99M 10-Q · filed 2020-11-16 | $12.78M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $3.24M 10-Q · filed 2020-08-14 | $6.59M 10-Q · filed 2020-08-14 | $9.38M derived: sum of 3 quarters · filed 2020-08-14 | $10.88M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $3.35M 10-Q · filed 2020-05-13 | $6.14M derived: sum of 2 quarters · filed 2020-05-13 | $7.64M derived: sum of 3 quarters · filed 2020-05-13 | $8.85M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $2.79M 10-K · filed 2020-04-03 | $4.29M derived: sum of 2 quarters · filed 2020-04-03 | $5.50M derived: sum of 3 quarters · filed 2020-04-03 | $7.42M 10-K · filed 2020-04-03 |
| 2018-09-30 | $1.50M 10-K · filed 2020-04-03 | $2.71M derived: sum of 2 quarters · filed 2020-04-03 | $4.63M 10-Q · filed 2019-11-14 | $5.82M derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | $1.21M 10-K · filed 2020-04-03 | $3.13M 10-Q · filed 2019-08-14 | $4.32M derived: sum of 3 quarters · filed 2020-04-03 | $6.07M derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | $1.93M 10-K · filed 2020-04-03 | $3.11M derived: sum of 2 quarters · filed 2020-04-03 | $4.86M derived: sum of 3 quarters · filed 2020-04-03 | $6.66M derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | $1.18M 10-K/A · filed 2019-04-23 | $2.93M derived: sum of 2 quarters · filed 2019-04-23 | $4.74M derived: sum of 3 quarters · filed 2019-04-23 | $6.66M 10-K/A · filed 2019-04-23 |
| 2017-09-30 | $1.75M 10-K/A · filed 2019-04-23 | $3.55M derived: sum of 2 quarters · filed 2019-04-23 | $5.47M 10-Q · filed 2018-11-14 | $6.79M derived: sum of 4 quarters · filed 2019-04-23 |
| 2017-06-30 | $1.80M 10-K/A · filed 2019-04-23 | $3.73M 10-Q · filed 2018-08-14 | $5.05M derived: sum of 3 quarters · filed 2019-04-23 | $6.66M derived: sum of 4 quarters · filed 2019-04-23 |
| 2017-03-31 | $1.92M 10-K/A · filed 2019-04-23 | $3.24M derived: sum of 2 quarters · filed 2019-04-23 | $4.86M derived: sum of 3 quarters · filed 2019-04-23 | $6.64M derived: sum of 4 quarters · filed 2019-04-23 |
| 2016-12-31 | $1.32M 10-K · filed 2018-04-17 | $2.93M derived: sum of 2 quarters · filed 2018-04-17 | $4.72M derived: sum of 3 quarters · filed 2018-04-17 | $8.37M 10-K · filed 2018-04-17 |
| 2016-09-30 | $1.61M 10-K · filed 2018-04-17 | $3.40M derived: sum of 2 quarters · filed 2018-04-17 | $7.05M 10-Q · filed 2017-11-14 | $9.26M derived: sum of 4 quarters · filed 2018-04-17 |
| 2016-06-30 | $1.78M 10-K · filed 2018-04-17 | $5.44M 10-Q · filed 2017-08-21 | $7.65M derived: sum of 3 quarters · filed 2018-04-17 | $9.71M derived: sum of 4 quarters · filed 2018-04-17 |
| 2016-03-31 | $3.66M 10-K · filed 2018-04-17 | $5.87M derived: sum of 2 quarters · filed 2018-04-17 | $7.92M derived: sum of 3 quarters · filed 2018-04-17 | $11.31M derived: sum of 4 quarters · filed 2018-04-17 |
| 2015-12-31 | $2.21M 10-K · filed 2017-03-31 | $4.27M derived: sum of 2 quarters · filed 2017-03-31 | $7.65M derived: sum of 3 quarters · filed 2017-03-31 | $11.00M 10-K · filed 2017-03-31 |
| 2015-09-30 | $2.06M 10-K · filed 2017-03-31 | $5.44M derived: sum of 2 quarters · filed 2017-03-31 | $8.79M 10-Q · filed 2016-11-14 | $12.53M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-06-30 | $3.38M 10-K · filed 2017-03-31 | $6.74M 10-Q · filed 2016-08-10 | $10.47M derived: sum of 3 quarters · filed 2017-03-31 | $14.60M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-03-31 | $3.35M 10-K · filed 2017-03-31 | $7.09M derived: sum of 2 quarters · filed 2017-03-31 | $11.22M derived: sum of 3 quarters · filed 2017-03-31 | $15.66M derived: sum of 4 quarters · filed 2017-03-31 |
| 2014-12-31 | $3.74M 10-K · filed 2016-03-29 | $7.86M derived: sum of 2 quarters · filed 2016-03-29 | $12.31M derived: sum of 3 quarters · filed 2016-03-29 | $16.73M 10-K · filed 2016-03-29 |
| 2014-09-30 | $4.13M 10-K · filed 2016-03-29 | $8.57M derived: sum of 2 quarters · filed 2016-03-29 | $12.99M 10-Q · filed 2015-11-05 | $17.07M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $4.45M 10-K · filed 2016-03-29 | $8.87M 10-Q · filed 2015-08-10 | $12.94M derived: sum of 3 quarters · filed 2016-03-29 | $17.24M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $4.42M 10-K · filed 2016-03-29 | $8.49M derived: sum of 2 quarters · filed 2016-03-29 | $12.79M derived: sum of 3 quarters · filed 2016-03-29 | $16.92M derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | $4.07M 10-K · filed 2015-03-16 | $8.37M derived: sum of 2 quarters · filed 2015-03-16 | $12.50M derived: sum of 3 quarters · filed 2015-03-16 | $16.72M 10-K · filed 2015-03-16 |
| 2013-09-30 | $4.30M 10-K · filed 2015-03-16 | $8.43M derived: sum of 2 quarters · filed 2015-03-16 | $12.65M 10-Q · filed 2014-11-07 | $19.18M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $4.13M 10-K · filed 2015-03-16 | $8.35M 10-Q · filed 2014-08-07 | $14.88M derived: sum of 3 quarters · filed 2015-03-16 | $19.14M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $4.22M 10-K · filed 2015-03-16 | $10.75M derived: sum of 2 quarters · filed 2015-03-16 | $15.01M derived: sum of 3 quarters · filed 2015-03-16 | $18.62M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $6.53M 10-K · filed 2014-03-17 | $10.79M derived: sum of 2 quarters · filed 2014-03-17 | $14.40M derived: sum of 3 quarters · filed 2014-03-17 | $16.44M 10-K · filed 2015-03-16 |
| 2012-09-30 | $4.25M 10-K · filed 2014-03-17 | $7.87M derived: sum of 2 quarters · filed 2014-03-17 | $9.91M 10-Q · filed 2013-11-12 | $11.80M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $3.61M 10-K · filed 2014-03-17 | $5.66M 10-Q · filed 2013-08-08 | $7.55M derived: sum of 3 quarters · filed 2014-03-17 | $9.73M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $2.05M 10-K · filed 2014-03-17 | $3.94M derived: sum of 2 quarters · filed 2014-03-17 | $6.13M derived: sum of 3 quarters · filed 2014-03-17 | $8.09M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $1.89M 10-K · filed 2013-03-15 | $4.08M derived: sum of 2 quarters · filed 2013-03-15 | $6.04M derived: sum of 3 quarters · filed 2013-03-15 | $7.86M 10-K · filed 2014-03-17 |
| 2011-09-30 | $2.19M 10-K · filed 2013-03-15 | $4.16M derived: sum of 2 quarters · filed 2013-03-15 | $5.97M 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $1.97M 10-K · filed 2013-03-15 | $3.79M 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $1.82M 10-K · filed 2013-03-15 | |||
| 2010-12-31 | $8.39M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |